Laurence Dumon-Seignovert

USPTO Granted Patents = 10 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

Years Active: 2013-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11814663 - Microorganisms with improved 1,3-propanediol and butyric acid production (2023-11-14),

2. 10889840 - Conversion of methylglyoxal into hydroxyacetone using novel enzymes and applications thereof (2021-01-12),

3. 10858675 - Modified microorganism for the optimized production of 2,4-dihydroxybutyrate with enhanced 2,4-dihydroxybutyrate efflux (2020-12-08),

4. 10801050 - Microorganism modified for the assimilation of levulinic acid (2020-10-13),

5. 10415062 - Modified microorganism for the optimized production of 2,4-dihydroxybutyrate (2019-09-17),

6. 10329591 - Method and microorganism for methionine production by fermentation with improved methionine efflux (2019-06-25),

7. 10059970 - Microorganism for methionine production with enhanced methionine efflux (2018-08-28),

8. 8980604 - Mutant glycerol dehydrogenase (GlyDH) for the production of a biochemical by fermentation (2015-03-17),

9. 8969053 - Mutant YqhD enzyme for the production of a biochemical by fermentation (2015-03-03),

10. 8497102 - Mutant methylglyoxal synthase (MGS) for the production of a biochemical by fermentation (2013-07-30),

Title: The Innovations of Laurence Dumon-Seignovert

Introduction

Laurence Dumon-Seignovert is a notable inventor based in Pont du Chateau, France. He has made significant contributions to the field of biotechnology, particularly in the production of valuable chemical compounds through microbial processes. With a total of 10 patents to his name, Dumon-Seignovert's work has the potential to impact various industries.

Latest Patents

One of his latest patents focuses on microorganisms with improved 1,3-propanediol and butyric acid production. This invention concerns a new mutant strain that comprises attenuated glycerol kinase activity. The modified strain is adapted for growth and production of 1,3-propanediol in a culture medium with high glycerol content. Additionally, the invention relates to a method for producing 1,3-propanediol and butyric acid by culturing this mutant strain. Another significant patent involves the conversion of methylglyoxal into hydroxyacetone using novel enzymes. This invention introduces new methylglyoxal reductase (MGR) enzymes that efficiently convert methylglyoxal into hydroxyacetone. The method also includes producing 1,2-propanediol using a microorganism that overexpresses these enzymes.

Career Highlights

Throughout his career, Laurence Dumon-Seignovert has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Metabolic Explorer and Evonik Degussa GmbH. His work in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Dumon-Seignovert has collaborated with several professionals in his field, including Philippe Soucaille and Wanda Dischert. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Laurence Dumon-Seignovert's contributions to biotechnology through his patents and collaborations highlight his innovative spirit and dedication to advancing the field. His work continues to pave the way for new methods in chemical production and microbial applications.

This text is generated by artificial intelligence and may not be accurate.